GENMAB ANNOUNCES DETAILS OF PLANNED OFATUMUMAB PHASE II STUDY IN MULTIPLE SCLEROSIS
Copenhagen, Denmark
December 13, 2007 –
Genmab A/S (OMX: GEN) announced ... more »
|
|||
|
Multiple Sclerosis Info
Search
This Month
|
Monday, January 7
OFATUMUMAB PHASE II STUDY IN MULTIPLE SCLEROSIS
by
multiplesclerosis
on Mon 07 Jan 2008 12:00 AM CST
|
||